![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 24863 |
FusionGeneSummary for NRIP1_HIBADH |
![]() |
Fusion gene information | Fusion gene name: NRIP1_HIBADH | Fusion gene ID: 24863 | Hgene | Tgene | Gene symbol | NRIP1 | HIBADH | Gene ID | 8204 | 11112 |
Gene name | nuclear receptor interacting protein 1 | 3-hydroxyisobutyrate dehydrogenase | |
Synonyms | RIP140 | NS5ATP1 | |
Cytomap | 21q11.2-q21.1 | 7p15.2 | |
Type of gene | protein-coding | protein-coding | |
Description | nuclear receptor-interacting protein 1nuclear factor RIP140receptor-interacting protein 140 | 3-hydroxyisobutyrate dehydrogenase, mitochondrial3'-hydroxyisobutyrate dehydrogenase | |
Modification date | 20180523 | 20180523 | |
UniProtAcc | P48552 | P31937 | |
Ensembl transtripts involved in fusion gene | ENST00000318948, ENST00000400199, ENST00000400202, | ENST00000265395, | |
Fusion gene scores | * DoF score | 10 X 3 X 7=210 | 7 X 5 X 5=175 |
# samples | 10 | 7 | |
** MAII score | log2(10/210*10)=-1.0703893278914 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(7/175*10)=-1.32192809488736 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: NRIP1 [Title/Abstract] AND HIBADH [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | NRIP1 | GO:0000122 | negative regulation of transcription by RNA polymerase II | 10364267 |
Hgene | NRIP1 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 7641693|10364267 |
Hgene | NRIP1 | GO:0071392 | cellular response to estradiol stimulus | 15831516 |
Tgene | HIBADH | GO:0006574 | valine catabolic process | 16466957 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | BRCA | TCGA-AN-A0FZ-01A | NRIP1 | chr21 | 16386665 | - | HIBADH | chr7 | 27570967 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5UTR-3CDS | ENST00000318948 | ENST00000265395 | NRIP1 | chr21 | 16386665 | - | HIBADH | chr7 | 27570967 | - |
intron-3CDS | ENST00000400199 | ENST00000265395 | NRIP1 | chr21 | 16386665 | - | HIBADH | chr7 | 27570967 | - |
5UTR-3CDS | ENST00000400202 | ENST00000265395 | NRIP1 | chr21 | 16386665 | - | HIBADH | chr7 | 27570967 | - |
Top |
FusionProtFeatures for NRIP1_HIBADH |
![]() |
Hgene | Tgene |
NRIP1 | HIBADH |
Modulates transcriptional activation by steroidreceptors such as NR3C1, NR3C2 and ESR1. Also modulatestranscriptional repression by nuclear hormone receptors. Positiveregulator of the circadian clock gene expression: stimulatestranscription of ARNTL/BMAL1, CLOCK and CRY1 by acting as acoactivator for RORA and RORC. {ECO:0000269|PubMed:10364267,ECO:0000269|PubMed:11509661, ECO:0000269|PubMed:11518808,ECO:0000269|PubMed:12554755, ECO:0000269|PubMed:15060175,ECO:0000269|PubMed:21628546, ECO:0000269|PubMed:7641693}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for NRIP1_HIBADH |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for NRIP1_HIBADH |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
NRIP1 | NR5A1, NR0B1, LDOC1, TEX11, CEP70, CTBP2, TRAF2, CCDC85B, CTBP1, HDAC5, RARA, NR3C1, YWHAQ, RXRA, ESR1, AHR, PPARA, PPARG, THRA, RXRB, JUN, PRMT1, HDAC3, CARM1, XPO1, KPNB1, ESRRA, ESRRB, ESRRG, ESR2, E2F1, ACTN2, CIB1, NR1H2, THRB, RORB, NR1H3, VDR, HNF4A, NR5A2, ELAVL1, CDK8, NR3C2, APP, FHL1, DNMT1, DNMT3A, DNMT3B, PPARGC1A, ARPC3, BRCA1, MAGEA10, HDAC1, HDAC2 | HIBADH | HIBADH, TRIM63, ELAVL1, BRCA1, ALDH1B1, ALDH6A1, MDH1, PDXK, SOD1, ZNF692 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for NRIP1_HIBADH |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for NRIP1_HIBADH |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | NRIP1 | C0014170 | Endometrial Neoplasms | 1 | CTD_human |
Hgene | NRIP1 | C0018801 | Heart failure | 1 | CTD_human |
Hgene | NRIP1 | C0027051 | Myocardial Infarction | 1 | CTD_human |
Hgene | NRIP1 | C0036341 | Schizophrenia | 1 | CTD_human |
Hgene | NRIP1 | C1458155 | Mammary Neoplasms | 1 | CTD_human |